HARROW, INC. — Director's Dealing 2015

Feb 3, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2015-02-01

Reporting Person: SAHAREK JOHN P. (Chief Commercial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (Right to Buy)	$4.16	2023-11-12	Common Stock (20000)		Direct
Option (Right to Buy)	$8.75	2024-03-03	Common Stock (5000)		Direct

Footnotes

F1: The stock option was granted on November 12, 2013 pursuant to the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan") and vests over a 3-year period, with 25% of the total number of shares subject to the option vesting on the one-year anniversary of the grant date and the remaining shares subject to the option vesting in equal installments each quarterly period following the one-year anniversary of the grant date.

F2: The stock option was granted on March 3, 2014 pursuant to the Plan and vests over a 4-year period, with 25% of the total number of shares subject to the option vesting on the one-year anniversary of the grant date and the remaining shares subject to the option vesting in equal installments each quarterly period following the one-year anniversary of the grant date.